Guaranteeing a reduction
in the spread of illness
An innovative product that can protect the public
from the risk of MRSA, P. aeurginosa and other HAIs.
NitroPep effectively kills bacteria and works effectively on regularly-handled surfaces, including door handles and grab rails.
Our technology prevents surface colonisation and biofilm formation, ensuring that surface ‘recontamination’ and onward transmission of bacteria can be prevented.
NitroPep’s combined result of surface modification renders any treated surface bactericidal. This is done with two key methods:
- A bespoke surface engineering process to activate
the metal surfaces
- Dip-coating the activated surfaces with an
Today there are few public health issues of greater importance, worldwide, than the spread of bacteria and virus such as MRSA, campylobacter, staff aureus, salmonella and other HAIs.
The specialist NitroPep coating ensures plastic and metal surfaces are protected from the spread of such bacteria, thanks to the coating’s ability to “lock in” disinfectant and antimicrobial actives.
Antibacterial treated toilet brush to prevent bacterial contamination and aid with cleaning.
The toilet brush is treated with chlorhexidine digluconate which is attached the surface and does not need repeat applications. The treated surface can kill 99.9 % of bacteria (P. aeruginosa and MRSA) in 5 minutes and 99.9 % of fungi (C. albicans) in 15 minutes.
Tests on the NitroPep technology have been conducted in independent specialist laboratories.
- Test methods and protocols have been conducted in line with established industry standards. Tests conducted against S. Aureus, P. Aeruginosa, MRSA and C.albicans.
- Tests were completed on different steel types, different bacteria which are common causes of HAIs and are readily transmissible.
- Tests also conducted with splash test surface challenges to replicate and assess impact of hospital cleaning regimes.
The results were outstanding.
In situ field testing has been carried out across 24 sites.
These have been tested across the multiple sites in Birmingham including clinical, laboratory, toilet and general meeting areas.
These trials demonstrated greater than 99% efficacy over an extended period of time.